M. Hülsmeyer

发表

High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene.

P. Coulie, W. Saenger, R. Hillig, 2001, Journal of molecular biology.

Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class

L. Audoly, A. Skerra, M. Hülsmeyer, 2015, Angiogenesis.

Structure of interleukin 4 mutant E9A suggests polar steering in receptor-complex formation.

M. Dreyer, M. Hülsmeyer, C. Scheufler, 2001, Acta crystallographica. Section D, Biological crystallography.

Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.

M. Pfreundschuh, M. Hülsmeyer, F. Neumann, 2009, Immunology letters.

Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution.

W. Sebald, M. Hülsmeyer, C. Scheufler, 1999, Journal of molecular biology.

Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.

W. Saenger, R. Misselwitz, A. Ziegler, 2005, Journal of molecular biology.

Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide

Rosa Sorrentino, Wolfram Saenger, Maria Teresa Fiorillo, 2004, The Journal of experimental medicine.

Allele-dependent Similarity between Viral and Self-peptide Presentation by HLA-B27 Subtypes*

Rosa Sorrentino, Wolfram Saenger, Maria Teresa Fiorillo, 2005, Journal of Biological Chemistry.

An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies

P. Kaye, A. Skerra, M. Hülsmeyer, 2009, Proceedings of the National Academy of Sciences.

HLA-B27 Subtypes Differentially Associated with Disease Exhibit Subtle Structural Alterations*

Wolfram Saenger, W. Saenger, W. Schröder, 2002, The Journal of Biological Chemistry.

A Major Histocompatibility Complex·Peptide-restricted Antibody and T Cell Receptor Molecules Recognize Their Target by Distinct Binding Modes

P. Coulie, W. Saenger, R. Stanfield, 2005, Journal of Biological Chemistry.

The Solvent-Inaccessible Cys67 Residue of HLA-B27 Contributes to T Cell Recognition of HLA-B27/Peptide Complexes1

M. Zeitz, K. Wucherpfennig, P. Bowness, 2004, The Journal of Immunology.

HLA-B 27 / Peptide Complexes HLA-B 27 Contributes to T Cell Recognition Residue of 67 The Solvent-Inaccessible

M. Zeitz, K. Wucherpfennig, P. Bowness, 2004 .

Thermodynamic and Structural Analysis of Peptide- and Allele-dependent Properties of Two HLA-B27 Subtypes Exhibiting Differential Disease Association*

W. Saenger, R. Misselwitz, R. Hillig, 2004, Journal of Biological Chemistry.

A single residue exchange between two HLA-B27 alleles triggers increased peptide flexibility

L. Nilsson, M. Hülsmeyer, Ewgeni B. Starikow, 2004, European Biophysics Journal.

In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer

E. D. de Vries, J. Kosterink, L. Audoly, 2014, The Journal of Nuclear Medicine.

- PRS-110 PET Tracer 89 the MET-Specific Anticalin In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with

J. Kosterink, L. Audoly, W. Nagengast, 2014 .

A Highly Potent and Specific MET Therapeutic Protein Antagonist with Both Ligand-Dependent and Ligand-Independent Activity

J. F. Burrows, L. Audoly, M. Hülsmeyer, 2013, Molecular Cancer Therapeutics.

Human CD30: Structural implications from epitope mapping and modeling studies

J. Schneider-Mergener, Liying Dong, A. Ziegler, 2003, Journal of molecular recognition : JMR.

Crystal structure of cis‐biphenyl‐2,3‐dihydrodiol‐2,3‐dehydrogenase from a PCB degrader at 2.0 Å resolution

D. Schomburg, K. Timmis, H. Hecht, 1998, Protein science : a publication of the Protein Society.

Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide

W. Saenger, A. Ziegler, M. Hülsmeyer, 2004, The Journal of experimental medicine.